Cite
APA Citation
Romano, F., Madia, F., De Marco, P., Ognibene, M., Guerrisi, S., Scala, M., Iacomino, M., Baldassari, S., Vercellino, N., Manunza, F., Tallone, R., Pavanello, M., Piatelli, G., Garaventa, A., Zara, F., & Capra, V. (2022). clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues. Birth defects research, 114(20), 1440–1448. http://access.bl.uk/ark:/81055/vdc_100172067009.0x00000b